A pioneering biobattery has been shown to reduce tumor growth in the body and could hold the key to a new drug-free immunotherapy treatment in cancer patients.

Cardiovascular diseases cause one death every 33 seconds in America. Diagnosing these conditions, which account for approximately 20% of all deaths annually, can be difficult because the overlaying and natural fluorescence of cardiac tissue complicate diagnostic images.

Mapping a human cell gives researchers a view of subcellular architecture and sheds light on how cancer develops.

SAN FRANCISCO, May 29, 2025 /PRNewswire/ — Darmiyan, Inc., a leading brain health technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s post-market surveillance study for BrainSee, its groundbreaking clinical prognostic tool for Alzheimer’s disease. This 7-year study aims to further validate the safety and effectiveness of BrainSee in a socio-demographically diverse patient population across the United States. The insights gained will also support pharmaceutical companies and contract research organizations (CROs) in identifying optimal candidates for next-generation Alzheimer’s clinical trials—advancing both precision and equity in patient selection.

CENTER VALLEY, Pa., May 29, 2025 /PRNewswire/ — Olympus Corp., a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, announced today the launch of the ScopeLocker Air endoscope drying cabinet, offering a new drying option for healthcare facilities.

Georgia Tech researchers have just shared a game-changing breakthrough: a nearly invisible brain-computer interface (BCI) that fits between hair follicles and sits just beneath the skin. No bulky headgear, no conductive gel – just a wireless sensor smaller than a millimeter, picking up brain signals with 96.4% accuracy, even while walking or running.

Empatica announced today that it received CE mark approval for its EpiMonitor epilepsy monitoring solution.

Distalmotion announced today that it received FDA 510(k) clearance for the use of its Dexter surgical robot in adult cholecystectomy (gallbladder removal).